Article: Spiriva Improved Lung Function in COPD Patients of African Descent.

- One of the First Studies to Explore Treatment Effectiveness in This Population -

SAN DIEGO, May 21 /PRNewswire/ -- New study results show that treatment with Spiriva(R) HandiHaler(R) (tiotropium bromide inhalation powder) significantly improved lung function in patients of African descent with COPD, chronic obstructive pulmonary disease.(1) The findings are important because COPD patients of African descent have been under-represented in clinical trials and may respond differently to COPD treatment than Caucasians do.(11) The study results were announced today at the American Thoracic Society's annual meeting.

"These data are an important ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!